Consolidated Restated 2018 2017 Note $'000- $'000 Revenue 150.638 155 182 Employee benefits expense (47,891) (46,260) Clinicians fees (26,088) (25,520) Raw materials and consumables used (14,521) (13,055) IT and communications expense (2,588) (2,580) Depreciation expense 2.2 Amortisation expense 2.3 (3,868) (3,617 (1,063) (744) Property expense (9.265) (8,094) Marketing and advertising expense (4,033) (4,718) Professional and other fees (3,236) (2,775) Other expenses (4.907) (3.206) Operating Profit 33.158 44.613 Finance income Finance expenses (3,562 (3,473) Net finance costs 4.4 (3,553) (3,460) Profit before tax 29,605 41, 153 Income tax expense 1.4 18.424 11,534 Profit for the year 21,181 29,619 Other comprehensive income Items that may be reclassified subsequently to profit or loss: Cash flow hedges 121 (67) Tax on cash flow hedges (36) 20 Exchange difference on translation of foreign operations 240 (261) Other comprehensive income for the year. net of tax 325 (308) Total comprehensive income for the year 21,506 29,311 Profit attributable to: Owners of the company 21,353 29.619 Non-controlling interests (172) Profit for the year 21,181 29,619 Total comprehensive income attributable to: Owners of the company 21,678 29,311 Non-controlling interests (172 Total comprehensive income for the year 21,506 29,311 Earnings per share Basic earnings per share (cents) 1.3 9.1 12.6 Diluted earnings per share (cents) 1.3 9.1 12.5 For improve insparency and cons to clinician fees. As such, the prior year comparalives have be certain salaried employees have been re-classified benefits expense by $1.619,000 linician fees by $1,619,000 and reducing employee The consolidated statement of profit or loss and other comprehensive income should be read in conjunction with the accompanying notes. = Profit after interest and tax = Connection between the three statements via the Retained Earnings Total Revenue"For improved transparency and consistency with internal management reporting purposes, certain salaried employees have been re-classified to clinician fees. As such, the prior year comparatives have been restated by increasing clinician fees by $1,619,000 and reducing employee benefits expense by $1,619,000 The consolidated statement of profit or loss and other comprehensive income should be read in conjunction with the accompanying notes. = Profit after interest and tax = Connection between the three statements via the Retained Earnings Total Revenue Revenue 150,638Finance Income 9 Total 150,647 Total Expenses Employee benefits expense 47,891 Clinicians fees 26,088 Raw materials and consumables used 14,521 IT and communications expense 2,588 Depreciation expense 3,888 Amortisation expense 1,063 Property expense 9,265 Marketing and advertising expense 4,033 Professional and other fees 3,236 Other expenses 4,907 Finance expenses 3,562 Income tax expense 8,424 Total 129,466 Profit after interest and tax Profit after interest and tax 21, 181 Total Revenue - Total Expenses = Profit after interest and tax 150,647 - 129,466 = 21, 181Consolidated 2018 2017 Note $'000 $'000 Current assets Cash and cash equivalents 4.5 3,853 3,502 Trade and other receivables 2.1 4,193 5,072 Current tax assets 2,040 Other assets 2.5 6,640 6,476 Total current assets 16,726 15,050 Non current assets Equity accounted investment 754 654 Trade and other receivables 2.1 85 112 Plant and equipment 2.2 16,935 16,750 Intangible assets 23 256, 111 254,688 Total non current assets 273,885 272,204 Total assets 290,611 287,254 Current liabilities Trade and other payables 2.4 14,045 17,304 Borrowings 4.3 (134) (116) Current tax liability 166 Employee benefits 3.1 7,926 7,603 Total current liabilities 21,837 24,957 Non current liabilities Trade and other payables 352 Borrowings 4.3 98,240 95,779 Employee benefits 3.1 798 962 Deferred tax liability 1.4 2,878 1.688 Total non current liabilities 101,916 98, 781 Total liabilities 123,753 123,738 Net assets 166,858 163,516 Equity Contributed equity 4.1 428,347 428,347 Reserves (137,035) (137,357) Profits reserve 36, 174 33,418 Retained earnings (160,892 (160,892) Total equity attributable to ordinary shareholders of Monash IVF Group limited 166,594 163,516 Non-controlling Interest 264 Total equity 166,858 163,516 The consolidated statement of financial position should be read in conjunction with the accompanying notes.10 = Total Assets Assets = Liabilities + Equity = Total Liabilities 290,611 = 123,753 + 166,858 = Total Equity 290, 611 = 290, 611 = Connection between the thr igsContributed Other equity Profits Retained Other equity reserve") reserve earnings reserves) To $000 $'00 0 $'000 $000 $'000 Consolidated Balance at 30 June 2016 428,347 (136,811) 24,513 (160,892) (282) 154,8 Profit for the year 29,619 29,6 Total other comprehensive income 308 (3 Total comprehensive income for the year 29,619 (308) 29,3 Transactions with owners in their capacity as owners directly in equity Share-based payment trans actions Dividends paid (20,714) (20,7 Consolidated Balance at 30 June 2017 428,347 (136,811) 33,418 (160,892) (546) 163,4 Profit for the year 21,353 21.3 Total other comprehensive income 325 Total comprehensive income/(loss) for the year 21,353 325 21.6 Transactions with owners in their capacity asowners directly in equity Share-based payment trans actions Capital contributions (3) Dividends paid (18,597) (18,5 Consolidated Balance at 30 June 2018 428,347 (136,81 1) 36,174 (160,892) (224) 166,5 " The Other equity reserve represents the difference between the Issued Capital in Healthbridge Enterprises Pty Lid and the consideration paid to acquire Healthbridge Enterp The Profits reserve comprises the transfer of net profit for the period and characterises profits available for distributions as dividends in future periods. "Other reserves includes share based payments, foreign currency translation and hedging reserve. pre-consolidated statement of changes in equity should be read in conjunction with the accompanying notes. = Reta = Share capital at the start of the period (There is no share capital) = Retained earnings at the end of the period = Share capital at the end of the period = Connection between the three statements via the Retained EarningsConsolidated 2018 2017 Note $'000 $'000 Cash flows from operating activities Receipts from customers 150,455 157,872 Payments to suppliers and employees (114,912) (111,895) Cash generated from operations 35,543 45,977 Income taxes paid (9,613) (20,068) Net cash flows generated from operating activities 4.5 25,930 25,909 Cash flows from investing activities Payments for property, plant and equipment (6,559) (6,603) Payments for subsidiaries (425 Net cash flows used in investing activities (6,559) (7,028) Cash flows from financing activities Receipt of borrowings 21,800 20,500 Receipt of loans receivable 22 54 Proceeds from non-controlling interest 436 Repayments of borrowings (19,300) (20,000) Interest paid (3,621) (3,430) Dividends paid (18,597) (20,714) Net cash flows used in financing activities (19,260) (23,590) Total cash flows from activities 111 (4,709) Cash and cash equivalents at the beginning of the year 3,502 8,472 Effects of exchange rate changes on foreign currency cash flows and cash balances 240 (261) Cash and cash equivalents at end of the year 4.5 3.853 3.502 = Net Operating Cash Flows = Net Investing Cash Flows = Net Financing Cash Flows = Net increase/decrease in cash and cash equivalents = Cash and Cash Equivalents at the start of the period = Cash and Cash Equivalents at the end of the periodIncome Statement 2018 Statement of changes in equity 2018 Net Revenue Beginning Retained Earnings 204.3 -Total expenses + Net Profit -Net Interest Expense - Dividends -Income Tax Expense + Reclassification of Retained Net Profit Earnings Retained Earnings Statement of Cash Flows 2018 Balance Sheet 2018 Net Increase in Cash and Cash and Cash Equivalents Cash Equivalents + Receivables + Cash and Cash Equivalents + Inventories at Beginning of Year + Other Assets - Effects of exchange rate changes Total Current Assets on cash and cash equivalents Cash and Cash Equivalents Issued Capital at end of Year + Reserves + Retained Earnings Cash and Cash Equivalents Equity Attributable to -Bank Overdrafts Shareholders Cash and Cash Equivalents at end of Year